Thrombosis and Haemostasis · 2006 · 106 citations · 21 references
MedicineOncologyPharmacologyCancer PharmacologyMetastasisMolecular OncologyAnticoagulant TherapyAnticoagulation TherapyHemostatic AgentsNatural Anticoagulant SystemsFondaparinux AnticoagulationHeparin AnticoagulationHeparin-mediated AnticoagulationHeparin-protein InteractionsLow-molecular-weight Heparin TherapyMetastasis SuppressionSelectin-mediated AdhesionSelectin-mediated Interactions
Ample evidence suggests that many of the in vivo anti-metastatic effects by heparins reflect their actions on P-selectin-mediated binding. We hypothesized that the ability of widely used heparins and derivatives to interfere with P-selectin-dependent tumour cell interactions under flow in vitro could be used to identify anticoagulants with advanced inhibitory functions on experimental blood-borne metastasis in vivo. To test this assumption, the impact of unfractionated heparin, the low-molecular-weight heparins (LMWH) nadroparin and enoxaparin, and the synthetic pentasaccharide fondaparinux on P-selectin-dependent tumour interactions in vitro and metastasis formation in vivo were evaluated. Our data revealed that these commonly used anticoagulants widely differ in their potential to interfere with P-selectinmediated cell binding. Importantly, the superior inhibitory capacity on P-selectin function of unfractionated heparin and LMWH nadroparin as opposed to LMWH enoxaparin and synthetic heparin pentasaccharide fondaparinux strongly correlated to the inhibitory potency of each in inhibiting experimental lung metastasis in vivo. Hence, P-selectin inhibition may constitute a valuable feature to identify anticoagulants that are suitable for anticancer therapy.
21
Lubor Borsig, Richard W. Wong, James R. Feramisco et al. · Proceedings of the National Academy of Sciences · 2001 · 710 citations · Full text
Medicine, Cancer Biology, Oncology +16
Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation
R M Nelson, O Cecconi, WG Roberts et al. · Blood · 1993 · 503 citations · Full text
Agnes Lee, Frederick R. Rickles, Jim A. Julian et al. · Journal of Clinical Oncology · 2005 · 453 citations · Full text
Medicine, Oncology, Pharmacology +13